Leveraging SARS-CoV-2-induced pre-existing humoral and cellular immunity for tumor elimination

International Immunopharmacology 2026

View at publisher

Authors: Lingxiao Chen, Qiumin Yu, Shukang Duan, Qiuli Mao, Y. F. Han, Siqi Tang, Wenbing Yao, Xiangdong Gao, Hong Wei Tian

DOI: 10.1016/j.intimp.2025.116114

Cited by: 0

References: 56

Fields of Study & Subjects

CAR-T cell therapy research Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses

References 56